Availability of and Access to Orphan Drugs: An International Comparison of Pharmaceutical Treatments for Pulmonary Arterial Hypertension, Fabry Disease, Hereditary Angioedema and Chronic Myeloid Leukaemia

Author： >   Stargardt Tom   Schreyögg Jonas  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.29, Iss.1, 2011-01, pp. : 63-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Pulmonary Arterial Hypertension in Connective Tissue Disease

By Grünig Ekkehard  

Drugs, Vol. 72, Iss. 8, 2012-05 ,pp. : 1039-1056

Adis International

Access to resources Recommend Favorite

An update on chronic myeloid leukaemia

By Stark Gail   O'Brien Stephen G  

Clinical Medicine, Vol. 1, Iss. 5, 2001-09 ,pp. : 354-357

Royal College Of Physicians

Access to resources Recommend Favorite

Emerging treatments in acute myeloid leukaemia

By Kell Jonathan  

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 55-71

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Transcutaneous, Arterial and End-tidal Measurements of Carbon Dioxide during Laparoscopic Cholecystectomy in Patients with Chronic Obstructive Pulmonary Disease

By Ozyuvaci E   Demircioglu O   Toprak N   Topacoglu H   Sitilci T   Akyol O  

The Journal of International Medical Research, Vol. 40, Iss. 5, 2012-09 ,pp. : 1982-1987

Field House Publishing

Access to resources Recommend Favorite

Once-Daily Nebivolol 5mg Does Not Reduce Airway Patency in Patients with Chronic Obstructive Pulmonary Disease and Arterial Hypertension: A Placebo-Controlled Crossover Study

By dal Negro R.W.   Tognella S.   Pomari C.  

Clinical Drug Investigation, Vol. 22, Iss. 6, 2002-06 ,pp. : 361-367

Adis International

Access to resources Recommend Favorite